(S) -3 - ((S) -5- (4-fluorophenyl) -5-hydroxypentanoyl) -4-phenyloxazolidin-2-ib CAS 189028-95-3

Khoom Qhia:

Khoom npe: (S) -3 - ((S) -5- (4-fluorophenyl) -5-hydroxypentanoyl) -4-phenyloxazolidin-2-ib CAS TSIS: 189028-95-3

Txhais:

3- [5- (p-fluorophenyl) -5-hydroxy-1-oxopentyl] -4-phenyl-2-oxazolidinone;

3 - [(5S) - (4-fluorophenyl) -5-hydroxypentanoyl] - (4S) -phenyl-1,3-oxazolidin-2-ib;

(4S) -4-phenyl-3 - [(5S) -5- (4-fluorophenyl) -5-hydroxypentanoyl] -1,3-oxazolidin-2-ib;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: Dawb rau Off-White hmoov

Ntsuas: ≥99.0%

Qhov ceev: 1.297g / cm3

Lub Ntsiab Kub: 572.73 ℃ ntawm 760 mmHg

Flash Point: 300.17 ℃

(S) -3 - ((S) -5- (4-Fluorophenyl) -5-hydroxypentanoyl) -4-phenyloxazolidin-2-ib yog siv rau Ezetimibe Intermediate.

Ezetimibe' s cov chaw kho mob tam sim no rau kev kho mob ntawm hyperlipidemia feem ntau muaj xws li cov roj cholesterol synthesis inhibitors, phenoxy acids thiab bile acid sequestrants. Ezetimibe ua haujlwm ntawm txhuam ciam ntawm cov plab hnyuv me me kom xaiv qhov haum rau kev nqus ntawm cov cholesterol hauv cov nplais thiab zaub mov yam tsis muaj kev cuam tshuam kev nqus ntawm cov roj-soluble vitamins, triglycerides thiab bile acid.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: (s) -3 - ((s) -5- (4-fluorophenyl) -5-hydroxypentanoyl) -4-phenyloxazolidin-2-ib li cas 189028-95-3, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: Rivaroxaban CAS 366789-02-8
• Tom ntej: (S) -1- (4-fluorophenyl) -5- (2-oxo-4-phenyloxazolidin-3-yl) pentane-1,5-dione CAS 189028-93-1